Skip to content
Bored Studies
RecruitingPhase 3

Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research

Oculis · NCT07623668

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–50 · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 3
Target enrollment
210
US sites recruiting
4
Study start
May 28, 2026
Record last updated
August 14, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON).

Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).

Being studied: Privosegtor; Methylprednisolone; Placebo

Conditions: Optic Neuritis

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Key Inclusion Criteria

  • Adult men and women (aged 18 to 50 years) with the first episode of ON in the study eye, associated with unilateral visual loss.
  • Onset of visual loss symptoms in the previous 12 days before first administration of study treatment.

Key Exclusion Criteria

  • Have a history or presence of any disorder or condition that may, in the opinion of the Investigator, likely interfere with the interpretation of the study results or participant safety

Recruiting US locations

  • Kahana Oculoplastic and Orbital Surgery

    Livonia, MI 48152

    Site contact: Dr. Victoria Williams · 248-800-1177 · kcrc@mioculoplastics.com

  • Medical University of South Carolina, Storm Eye Institute

    Charleston, SC 29425

  • UT Southwestern Medical Center (Ophthalmology CRU)

    Dallas, TX 75390

    Site contact: Ruben Jauregui, MD · 214-645-2014 · OphthaResearch@UTSouthwestern.edu

  • Neuro-Eye Clinical Trials

    Houston, TX 77074

    Site contact: Mirna Maldonado · 713-894-4393 · Rtang@neuroeye.com

Study contacts (from the official record)

  • Chief Development Officer · 617-928-5886 · info@oculis.com
All neurology studies in Michigan →
Privosegtor Investigation in Optic Neuropathies Efficacy… (NCT07623668) | Bored Studies